Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Thescientificworldjournal
|
September 5, 2006
New perspectives on aspirin and the endogenous control of acute inflammatory resolution
Thea Morris, Melanie Stables, Derek W Gilroy
Trends in Pharmacological Sciences
|
October 24, 2006
Not all eicosanoids are bad
Thea Morris, Ravindra Rajakariar, Melanie Stables, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 28, 2010
Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways
Thea Morris, Melanie Stables, Paul Colville-Nash, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 2009
Effects of low-dose aspirin on acute inflammatory responses in humans
Thea Morris, Melanie Stables, Adrian Hobbs, et al.
Leukemia
|
May 12, 2018
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Stephan Stilgenbauer, Veronique Leblond, Robin Foà, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Thescientificworldjournal
|
September 5, 2006
New perspectives on aspirin and the endogenous control of acute inflammatory resolution
Thea Morris, Melanie Stables, Derek W Gilroy
Trends in Pharmacological Sciences
|
October 24, 2006
Not all eicosanoids are bad
Thea Morris, Ravindra Rajakariar, Melanie Stables, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 28, 2010
Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways
Thea Morris, Melanie Stables, Paul Colville-Nash, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 2009
Effects of low-dose aspirin on acute inflammatory responses in humans
Thea Morris, Melanie Stables, Adrian Hobbs, et al.
Leukemia
|
May 12, 2018
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Stephan Stilgenbauer, Veronique Leblond, Robin Foà, et al.
Page
of 1